drugset / Trial / NCT02316236

Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery

NCT02316236 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The study is to observe whether dexmedetomidine could reduce agitation during emergence from general anesthesia in patients undergoing retroperitoneal laparoscopic surgery.

Timeline

Start
2014-12-10
Primary completion
2015-08-12
Completion
2015-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg —
Subject Dexmedetomidine Other / unclassified 0.8 ug/kg —

Indications

No indication recorded.